Announcements

Pfizer & BioNTech’s mRNA Vaccine Study Begins

See Clinical Studies for more information.

October 15, 2020

REGN-COV2 Antibody Therapy Used for Treatment Study Also Implemented in CoVPN Prevention Study

REGN-COV-2 is testing a combination of two antibodies called REGN10933 and REGN10987 to determine whether they can prevent SARS-CoV-2, the virus that causes COVID-19. Learn more about the study and the antibodies.

October 8, 2020

Interested in volunteering for a COVID-19 Prevention Clinical Study?

Selecting the button below will take you to the CoVPN Volunteer Screening Registry.

Volunteer Now!

Or register by calling 1-866-288-1919.